Ceftazidime/avibactam sodium
Term · Oncology and biomedicine · MLC-T-ONC-012501
A combination preparation containing the third-generation cephalosporin ceftazidime and the sodium salt form of avibactam, a non-beta-lactam beta-lactamase inhibitor, with antibiotic and beta-lactamase inhibiting activity, respectively. Upon administration, ceftazidime binds to essential penicillin-binding proteins (PBPs) and inhibits cell wall synthesis in certain bacteria. Avibactam binds to and inactivates beta-lactamases, thereby protecting ceftazidime from degradation and increasing ceftazidime’s efficacy.
| Identifier | MLC-T-ONC-012501 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | ceftazidime-avibactam sodium; CAZ-AVI |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012501",
"term": "Ceftazidime/avibactam sodium",
"field": "Oncology and biomedicine",
"definition": "A combination preparation containing the third-generation cephalosporin ceftazidime and the sodium salt form of avibactam, a non-beta-lactam beta-lactamase inhibitor, with antibiotic and beta-lactamase inhibiting activity, respectively. Upon administration, ceftazidime binds to essential penicillin-binding proteins (PBPs) and inhibits cell wall synthesis in certain bacteria. Avibactam binds to and inactivates beta-lactamases, thereby protecting ceftazidime from degradation and increasing ceftazidime’s efficacy.",
"synonyms": [
"ceftazidime-avibactam sodium",
"CAZ-AVI"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/ceftazidime-avibactam-sodium/"
}
Record 4,539 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.